GPP

Great Point Partners Portfolio holdings

AUM $154M
1-Year Est. Return 2.36%
This Quarter Est. Return
1 Year Est. Return
-2.36%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$637M
AUM Growth
+$3.94M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
42
New
Increased
Reduced
Closed

Top Buys

1
+$28.5M
2
+$18M
3
+$16.7M
4
EXEL icon
Exelixis
EXEL
+$13.1M
5
VYNE icon
VYNE Therapeutics
VYNE
+$12.8M

Top Sells

1
+$40M
2
+$34.8M
3
+$22.3M
4
ACAD icon
Acadia Pharmaceuticals
ACAD
+$16.7M
5
ALXN
Alexion Pharmaceuticals
ALXN
+$13.7M

Sector Composition

1 Healthcare 96.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
1
$60.9M 9.49%
7,978,275
+500,000
2
$52.5M 8.19%
917,767
+159,767
3
$39.6M 6.18%
282,615
-9,052
4
$39.3M 6.13%
3,496,340
+10,595
5
$38.4M 5.98%
300,000
+130,361
6
$37.1M 5.78%
2,119,106
-508,004
7
$36.8M 5.73%
2,075,000
+740,207
8
$33.7M 5.26%
717,458
-851,042
9
$28.5M 4.45%
+1,606,100
10
$26.5M 4.13%
1,400,000
+669,990
11
$26.3M 4.09%
300,000
+39,900
12
$25M 3.9%
2,243,084
+1,068,543
13
$24.8M 3.87%
1,196,098
-803,902
14
$23.1M 3.6%
4,030,268
-751,440
15
$22.9M 3.57%
1,647,753
+387,753
16
$21.5M 3.35%
2,179,688
+735,207
17
$21.4M 3.34%
393,147
-106,853
18
$18M 2.8%
+210,400
19
$12.8M 2%
+18,117
20
$10.9M 1.7%
+1,950,000
21
$10.1M 1.58%
982,449
-491,160
22
$9.79M 1.53%
+129,060
23
$8.65M 1.35%
+40,400
24
$3.8M 0.59%
+241,970
25
$2M 0.31%
+28,571
1
2